EXHIBIT 10.3
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.
COMMON STOCK PURCHASE WARRANT
To Purchase 3,476,190 Shares of Common Stock of
NEW CENTURY COMPANIES, INC.
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for
value received, CAMOFI MASTER LDC (the "Holder"), is entitled, upon the terms
and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the "Initial Exercise Date") and
on or prior to the close of business on February 28, 2013, the seven year
anniversary of the Initial Exercise Date (the "Termination Date") but not
thereafter, to subscribe for and purchase from New Century Companies, Inc., a
Delaware corporation (the "Company"), 3,476,190 shares (the "Warrant Shares") of
Common Stock, $0.10 par value, of the Company (the "Common Stock"). The purchase
price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).
Section 1. Definitions. Capitalized terms used and not otherwise
defined herein shall have the meanings set forth in that
certain Securities Purchase Agreement (the "Purchase
Agreement"), dated February 28, 2006, between the Company and
the purchaser signatory thereto.
Section 2. Exercise.
--------- --------
a) Exercise of Warrant. Exercise of the purchase rights
represented by this Warrant may be made at any time
or times on or after the Initial Exercise Date and on
or before the Termination Date by delivery to the
Company of a duly executed facsimile copy of the
Notice of Exercise Form annexed hereto (or such other
office or agency of the Company as it may designate
by notice in writing to the registered Holder at the
address of such Holder appearing on the books of the
Company); provided, however, within 5 Trading Days of
the date said Notice of Exercise is delivered to the
Company, the Holder shall have surrendered this
Warrant to the Company and the Company shall have
received payment of the aggregate Exercise Price of
the shares thereby purchased by wire transfer or
cashier's check drawn on a United States bank.
b) Exercise Price. The exercise price of the Common
Stock under this Warrant shall be $0.63 (the
"Exercise Price"). The Exercise Price shall be
subject to adjustment pursuant to Section 3 hereof.
c) Cashless Exercise. In the event that there is no
effective registration statement covering the resale
of the shares underlying this Warrant, this Warrant
may also be exercised by means of a "cashless
exercise" in which the Holder shall be entitled to
receive a certificate for the number of Warrant
Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:
(A) = the VWAP on the Trading Day immediately
preceding the date of such election;
(B) = the Exercise Price of this Warrant, as
adjusted; and
(X) = the number of Warrant Shares issuable upon
exercise of this Warrant in accordance with
the terms of this Warrant by means of a cash
exercise rather than a cashless exercise.
d) Exercise Limitations; ▇▇▇▇▇▇'s Restrictions. The
Holder shall not have the right to exercise any
portion of this Warrant, pursuant to Section 2(c) or
otherwise, to the extent that after giving effect to
such issuance after exercise, the Holder (together
with the Holder's affiliates), as set forth on the
applicable Notice of Exercise, would beneficially own
in excess of 4.99% of the number of shares of the
Common Stock outstanding immediately after giving
effect to such issuance. For purposes of the
foregoing sentence, the number of shares of Common
Stock beneficially owned by the Holder and its
affiliates shall include the number of shares of
Common Stock issuable upon exercise of this Warrant
with respect to which the determination of such
sentence is being made, but shall exclude the number
of shares of Common Stock which would be issuable
upon (A) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the
Holder or any of its affiliates and (B) exercise or
conversion of the unexercised or nonconverted portion
of any other securities of the Company (including,
without limitation, any other Notes or Warrants)
subject to a limitation on conversion or exercise
analogous to the limitation contained herein
beneficially owned by the Holder or any of its
affiliates. Except as set forth in the preceding
sentence, for purposes of this Section 2(d),
beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act, it
being acknowledged by Holder that the Company is not
representing to Holder that such calculation is in
compliance with Section 13(d) of the Exchange Act and
Holder is solely responsible for any schedules
required to be filed in accordance therewith. To the
extent that the limitation contained in this Section
2(d) applies, the determination of whether this
Warrant is exercisable (in relation to other
securities owned by the Holder) and of which a
portion of this Warrant is exercisable shall be in
the sole discretion of such ▇▇▇▇▇▇, and the
submission of a Notice of Exercise shall be deemed to
be such Holder's determination of whether this
Warrant is exercisable (in relation to other
securities owned by such Holder) and of which portion
of this Warrant is exercisable, in each case subject
to such aggregate percentage limitation, and the
Company shall have no obligation to verify or confirm
the accuracy of such determination. For purposes of
2 of 15
this Section 2(d), in determining the number of
outstanding shares of Common Stock, the Holder may
rely on the number of outstanding shares of Common
Stock as reflected in (x) the Company's most recent
Form 10-QSB or Form 10-KSB (or similar form), as the
case may be, (y) a more recent public announcement by
the Company or (z) any other notice by the Company or
the Company's Transfer Agent setting forth the number
of shares of Common Stock outstanding. Upon the
written or oral request of the Holder, the Company
shall within two Trading Days confirm orally and in
writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of
outstanding shares of Common Stock shall be
determined after giving effect to the conversion or
exercise of securities of the Company, including this
Warrant, by the Holder or its affiliates since the
date as of which such number of outstanding shares of
Common Stock was reported. The provisions of this
Section 2(d) may be waived by the Holder upon, at the
election of the Holder, not less than 61 days' prior
notice to the Company, and the provisions of this
Section 2(d) shall continue to apply until such 61st
day (or such later date, as determined by the Holder,
as may be specified in such notice of waiver).
e) Mechanics of Exercise.
i) Authorization of Warrant Shares. The Company
covenants that all Warrant Shares which may
be issued upon the exercise of the purchase
rights represented by this Warrant will,
upon exercise of the purchase rights
represented by this Warrant, be duly
authorized, validly issued, fully paid and
nonassessable and free from all taxes, liens
and charges in respect of the issue thereof
(other than taxes in respect of any transfer
occurring contemporaneously with such
issue). The Company covenants that during
the period the Warrant is outstanding, it
will reserve from its authorized and
unissued Common Stock a sufficient number of
shares to provide for the issuance of the
Warrant Shares upon the exercise of any
purchase rights under this Warrant. The
Company further covenants that its issuance
of this Warrant shall constitute full
authority to its officers who are charged
with the duty of executing stock
certificates to execute and issue the
necessary certificates for the Warrant
Shares upon the exercise of the purchase
rights under this Warrant. The Company will
take all such reasonable action as may be
necessary to assure that such Warrant Shares
may be issued as provided herein without
violation of any applicable law or
regulation, or of any requirements of the
Trading Market upon which the Common Stock
may be listed.
ii) Delivery of Certificates Upon Exercise.
Certificates for shares purchased hereunder
shall be transmitted by the transfer agent
of the Company to the Holder by crediting
the account of the Holder's prime broker
with the Depository Trust Company through
its Deposit Withdrawal Agent Commission
("DWAC") system if the Company is a
participant in such system, and otherwise by
physical delivery to the address specified
by the Holder in the Notice of Exercise
within 3 Trading Days from the delivery to
the Company of the Notice of Exercise Form,
surrender of this Warrant and payment of the
aggregate Exercise Price as set forth above
("Warrant Share Delivery Date"). This
Warrant shall be deemed to have been
exercised on the date the Exercise Price is
3 of 15
received by the Company. The Warrant Shares
shall be deemed to have been issued, and
Holder or any other person so designated to
be named therein shall be deemed to have
become a holder of record of such shares for
all purposes, as of the date the Warrant has
been exercised by payment to the Company of
the Exercise Price and all taxes required to
be paid by the Holder, if any, pursuant to
Section 2(e)(vii) prior to the issuance of
such shares, have been paid.
iii) Delivery of New Warrants Upon Exercise. If
this Warrant shall have been exercised in
part, the Company shall, at the time of
delivery of the certificate or certificates
representing Warrant Shares, deliver to
Holder a new Warrant evidencing the rights
of Holder to purchase the unpurchased
Warrant Shares called for by this Warrant,
which new Warrant shall in all other
respects be identical with this Warrant.
iv) Rescission Rights. If the Company fails to
cause its transfer agent to transmit to the
Holder a certificate or certificates
representing the Warrant Shares pursuant to
this Section 2(e)(iv) by the Warrant Share
Delivery Date, then the Holder will have the
right to rescind such exercise.
v) Compensation for Buy-In on Failure to Timely
Deliver Certificates Upon Exercise. In
addition to any other rights available to
the Holder, if the Company fails to cause
its transfer agent to transmit to the Holder
a certificate or certificates representing
the Warrant Shares pursuant to an exercise
on or before the Warrant Share Delivery
Date, and if after such date the Holder is
required by its broker to purchase (in an
open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant
Shares which the Holder anticipated
receiving upon such exercise (a "Buy-In"),
then the Company shall (1) pay in cash to
the Holder the amount by which (x) the
Holder's total purchase price (including
brokerage commissions, if any) for the
shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (A)
the number of Warrant Shares that the
Company was required to deliver to the
Holder in connection with the exercise at
issue times (B) the price at which the sell
order giving rise to such purchase
obligation was executed, and (2) at the
option of the Holder, either reinstate the
portion of the Warrant and equivalent number
of Warrant Shares for which such exercise
was not honored or deliver to the Holder the
number of shares of Common Stock that would
have been issued had the Company timely
complied with its exercise and delivery
obligations hereunder. For example, if the
Holder purchases Common Stock having a total
purchase price of $11,000 to cover a Buy-In
with respect to an attempted exercise of
shares of Common Stock with an aggregate
sale price giving rise to such purchase
obligation of $10,000, under clause (1) of
4 of 15
the immediately preceding sentence the
Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company
written notice indicating the amounts
payable to the Holder in respect of the
Buy-In, together with applicable
confirmations and other evidence reasonably
requested by the Company. Nothing herein
shall limit a Holder's right to pursue any
other remedies available to it hereunder, at
law or in equity including, without
limitation, a decree of specific performance
and/or injunctive relief with respect to the
Company's failure to timely deliver
certificates representing shares of Common
Stock upon exercise of the Warrant as
required pursuant to the terms hereof.
vi) No Fractional Shares or Scrip. No fractional
shares or scrip representing fractional
shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share
which Holder would otherwise be entitled to
purchase upon such exercise, the Company
shall pay a cash adjustment in respect of
such final fraction in an amount equal to
such fraction multiplied by the Exercise
Price.
vii) Charges, Taxes and Expenses. Issuance of
certificates for Warrant Shares shall be
made without charge to the Holder for any
issue or transfer tax or other incidental
expense in respect of the issuance of such
certificate, all of which taxes and expenses
shall be paid by the Company, and such
certificates shall be issued in the name of
the Holder or in such name or names as may
be directed by the Holder; provided,
however, that in the event certificates for
Warrant Shares are to be issued in a name
other than the name of the Holder, this
Warrant when surrendered for exercise shall
be accompanied by the Assignment Form
attached hereto duly executed by the Holder;
and the Company may require, as a condition
thereto, the payment of a sum sufficient to
reimburse it for any transfer tax incidental
thereto.
viii) Closing of Books. The Company will not close
its stockholder books or records in any
manner which prevents the timely exercise of
this Warrant, pursuant to the terms hereof.
Section 3. Certain Adjustments.
a) Stock Dividends and Splits. If the Company, at any time while
this Warrant is outstanding: (A) pays a stock dividend or
otherwise make a distribution or distributions on shares of
its Common Stock or any other equity or equity equivalent
securities payable in shares of Common Stock (which, for
avoidance of doubt, shall not include any shares of Common
Stock issued by the Company pursuant to this Warrant), (B)
subdivides outstanding shares of Common Stock into a larger
number of shares, (C) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller
number of shares, or (D) issues by reclassification of shares
of the Common Stock any shares of capital stock of the
Company, then in each case the Exercise Price shall be
multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock (excluding treasury shares,
if any) outstanding before such event and of which the
denominator shall be the number of shares of Common Stock
outstanding after such event and the number of shares issuable
upon exercise of this Warrant shall be proportionately
adjusted. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for
the determination of stockholders entitled to receive such
dividend or distribution and shall become effective
immediately after the effective date in the case of a
subdivision, combination or re-classification.
5 of 15
b) Subsequent Equity Sales. If the Company or any Subsidiary
thereof, as applicable, at any time while this Warrant is
outstanding, shall offer, sell, grant any option to purchase
or offer, sell or grant any right to reprice its securities,
or otherwise dispose of or issue (or announce any offer, sale,
grant or any option to purchase or other disposition) any
Common Stock or Common Stock Equivalents entitling any Person
to acquire shares of Common Stock, at an effective price per
share less than the then Exercise Price (such lower price, the
"Base Share Price" and such issuances collectively, a
"Dilutive Issuance"), as adjusted hereunder (if the holder of
the Common Stock or Common Stock Equivalents so issued shall
at any time, whether by operation of purchase price
adjustments, reset provisions, floating conversion, exercise
or exchange prices or otherwise, or due to warrants, options
or rights per share which is issued in connection with such
issuance, be entitled to receive shares of Common Stock at an
effective price per share which is less than the Exercise
Price, such issuance shall be deemed to have occurred for less
than the Exercise Price), then, the Exercise Price shall be
reduced to equal the Base Share Price and the number of
Warrant Shares issuable hereunder shall be increased such that
the aggregate Exercise Price payable hereunder, after taking
into account the decrease in the Exercise Price, shall be
equal to the aggregate Exercise Price prior to such
adjustment. Such adjustment shall be made whenever such Common
Stock or Common Stock Equivalents are issued. Such adjustment
shall be made whenever such Common Stock or Common Stock
Equivalents are issued. The Company shall notify the Holder in
writing, no later than the Trading Day following the issuance
of any Common Stock or Common Stock Equivalents subject to
this section, indicating therein the applicable issuance
price, or of applicable reset price, exchange price,
conversion price and other pricing terms (such notice the
"Dilutive Issuance Notice"). For purposes of clarification,
whether or not the Company provides a Dilutive Issuance Notice
pursuant to this Section 3(b), upon the occurrence of any
Dilutive Issuance, after the date of such Dilutive Issuance
the Holder is entitled to receive a number of Warrant Shares
based upon the Base Share Price regardless of whether the
Holder accurately refers to the Base Share Price in the Notice
of Exercise.
c) Pro Rata Distributions. If the Company, at any time prior to
the Termination Date, shall distribute to all holders of
Common Stock (and not to Holders of the Warrants) evidences of
its indebtedness or assets or rights or warrants to subscribe
for or purchase any security other than the Common Stock
(which shall be subject to Section 3(b)), then in each such
case the Exercise Price shall be adjusted by multiplying the
Exercise Price in effect immediately prior to the record date
fixed for determination of stockholders entitled to receive
such distribution by a fraction of which the denominator shall
be the VWAP determined as of the record date mentioned above,
and of which the numerator shall be such VWAP on such record
date less the then per share fair market value at such record
date of the portion of such assets or evidence of indebtedness
so distributed applicable to one outstanding share of the
Common Stock as determined by the Board of Directors in good
6 of 15
faith. In either case the adjustments shall be described in a
statement provided to the Holders of the portion of assets or
evidences of indebtedness so distributed or such subscription
rights applicable to one share of Common Stock. Such
adjustment shall be made whenever any such distribution is
made and shall become effective immediately after the record
date mentioned above.
d) Calculations. All calculations under this Section 3 shall be
made to the nearest cent or the nearest 1/100th of a share, as
the case may be. The number of shares of Common Stock
outstanding at any given time shall not includes shares of
Common Stock owned or held by or for the account of the
Company, and the description of any such shares of Common
Stock shall be considered on issue or sale of Common Stock.
For purposes of this Section 3, the number of shares of Common
Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock
(excluding treasury shares, if any) issued and outstanding.
e) Notice to Holders.
i. Adjustment to Exercise Price. Whenever the
Exercise Price is adjusted pursuant to this Section 3, the
Company shall promptly mail to each Holder a notice setting
forth the Exercise Price after such adjustment and setting
forth a brief statement of the facts requiring such
adjustment. If the Company issues a variable rate security,
despite the prohibition thereon in the Purchase Agreement, the
Company shall be deemed to have issued Common Stock or Common
Stock Equivalents at the lowest possible conversion or
exercise price at which such securities may be converted or
exercised in the case of a Variable Rate Transaction (as
defined in the Purchase Agreement), or the lowest possible
adjustment price in the case of an MFN Transaction (as defined
in the Purchase Agreement.
ii. Notice to Allow Exercise by ▇▇▇▇▇▇. If (A) the
Company shall declare a dividend (or any other distribution)
on the Common Stock; (B) the Company shall declare a special
nonrecurring cash dividend on or a redemption of the Common
Stock; (C) the Company shall authorize the granting to all
holders of the Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of
any rights; (D) the approval of any stockholders of the
Company shall be required in connection with any
reclassification of the Common Stock, any consolidation or
merger to which the Company is a party, any sale or transfer
of all or substantially all of the assets of the Company, of
any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property; (E) the
Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the
Company; then, in each case, the Company shall cause to be
mailed to the Holder at its last addresses as it shall appear
upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date
hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record
is not to be taken, the date as of which the holders of the
Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be
7 of 15
determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is
expected to become effective or close, and the date as of
which it is expected that holders of the Common Stock of
record shall be entitled to exchange their shares of the
Common Stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; provided, that the failure
to mail such notice or any defect therein or in the mailing
thereof shall not affect the validity of the corporate action
required to be specified in such notice. The Holder is
entitled to exercise this Warrant during the 20-day period
commencing the date of such notice to the effective date of
the event triggering such notice.
f) Fundamental Transaction. If, at any time while this Warrant is
outstanding, (A) the Company effects any merger or
consolidation of the Company with or into another Person, (B)
the Company effects any sale of all or substantially all of
its assets in one or a series of related transactions, (C) any
tender offer or exchange offer (whether by the Company or
another Person) is completed pursuant to which holders of
Common Stock are permitted to tender or exchange their shares
for other securities, cash or property, or (D) the Company
effects any reclassification of the Common Stock or any
compulsory share exchange pursuant to which the Common Stock
is effectively converted into or exchanged for other
securities, cash or property (in any such case, a "Fundamental
Transaction"), then, upon any subsequent conversion of this
Warrant, the Holder shall have the right to receive, for each
Warrant Share that would have been issuable upon such exercise
absent such Fundamental Transaction, at the option of the
Holder, (a) upon exercise of this Warrant, the number of
shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving
corporation, and Alternate Consideration receivable upon or as
a result of such reorganization, reclassification, merger,
consolidation or disposition of assets by a Holder of the
number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such event or (b) cash equal
to the value of this Warrant as determined in accordance with
the Black-Scholes option pricing formula (the "Alternate
Consideration"). For purposes of any such exercise, the
determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one
share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate
Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice
as to the securities, cash or property to be received in a
Fundamental Transaction, then the Holder shall be given the
same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental
Transaction. To the extent necessary to effectuate the
foregoing provisions, any successor to the Company or
surviving entity in such Fundamental Transaction shall issue
to the Holder a new warrant consistent with the foregoing
provisions and evidencing the Holder's right to exercise such
warrant into Alternate Consideration. The terms of any
agreement pursuant to which a Fundamental Transaction is
effected shall include terms requiring any such successor or
surviving entity to comply with the provisions of this
paragraph (f) and insuring that this Warrant (or any such
replacement security) will be similarly adjusted upon any
subsequent transaction analogous to a Fundamental Transaction.
8 of 15
g) Exempt Issuance. Notwithstanding the foregoing, no
adjustments, Alternate Consideration nor notices shall be
made, paid or issued under this Section 3 in respect of an
Exempt Issuance.
h) Voluntary Adjustment By Company. The Company may at any time
during the term of this Warrant reduce the then current
Exercise Price to any amount and for any period of time deemed
appropriate by the Board of Directors of the Company.
Section 4. Transfer of Warrant.
a) Transferability. Subject to compliance with any applicable
securities laws and the conditions set forth in Sections 5(a)
and 4(d) hereof and to the provisions of Section 4.1 of the
Purchase Agreement, this Warrant and all rights hereunder are
transferable, in whole or in part, upon surrender of this
Warrant at the principal office of the Company, together with
a written assignment of this Warrant substantially in the form
attached hereto duly executed by the Holder or its agent or
attorney and funds sufficient to pay any transfer taxes
payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and
deliver a new Warrant or Warrants in the name of the assignee
or assignees and in the denomination or denominations
specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this
Warrant not so assigned, and this Warrant shall promptly be
cancelled. A Warrant, if properly assigned, may be exercised
by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.
b) New Warrants. This Warrant may be divided or combined with
other Warrants upon presentation hereof at the aforesaid
office of the Company, together with a written notice
specifying the names and denominations in which new Warrants
are to be issued, signed by the Holder or its agent or
attorney. Subject to compliance with Section 4(a), as to any
transfer which may be involved in such division or
combination, the Company shall execute and deliver a new
Warrant or Warrants in exchange for the Warrant or Warrants to
be divided or combined in accordance with such notice.
c) Warrant Register. The Company shall register this Warrant,
upon records to be maintained by the Company for that purpose
(the "Warrant Register"), in the name of the record Holder
hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof
for the purpose of any exercise hereof or any distribution to
the Holder, and for all other purposes, absent actual notice
to the contrary.
d) Transfer Restrictions. If, at the time of the surrender of
this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be registered pursuant
to an effective registration statement under the Securities
Act and under applicable state securities or blue sky laws,
the Company may require, as a condition of allowing such
transfer (i) that the Holder or transferee of this Warrant, as
the case may be, furnish to the Company a written opinion of
counsel (which opinion shall be in form, substance and scope
customary for opinions of counsel in comparable transactions)
to the effect that such transfer may be made without
registration under the Securities Act and under applicable
9 of 15
state securities or blue sky laws, (ii) that the holder or
transferee execute and deliver to the Company an investment
letter in form and substance acceptable to the Company and
(iii) that the transferee be an "accredited investor" as
defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or (a)(8)
promulgated under the Securities Act or a qualified
institutional buyer as defined in Rule 144A(a) under the
Securities Act.
Section 5. Miscellaneous.
a) Title to Warrant. Prior to the Termination Date and subject to
compliance with applicable laws and Section 4 of this Warrant,
this Warrant and all rights hereunder are transferable, in
whole or in part, at the office or agency of the Company by
the Holder in person or by duly authorized attorney, upon
surrender of this Warrant together with the Assignment Form
annexed hereto properly endorsed. The transferee shall sign an
investment letter in form and substance reasonably
satisfactory to the Company.
b) No Rights as Shareholder Until Exercise. This Warrant does not
entitle the Holder to any voting rights or other rights as a
shareholder of the Company prior to the exercise hereof. Upon
the surrender of this Warrant and the payment of the aggregate
Exercise Price (or by means of a cashless exercise), the
Warrant Shares so purchased shall be and be deemed to be
issued to such Holder as the record owner of such shares as of
the close of business on the later of the date of such
surrender or payment.
c) Loss, Theft, Destruction or Mutilation of Warrant. The Company
covenants that upon receipt by the Company of evidence
reasonably satisfactory to it of the loss, theft, destruction
or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory
to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation
of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock
certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.
d) Saturdays, Sundays, Holidays, etc. If the last or appointed
day for the taking of any action or the expiration of any
right required or granted herein shall be a Saturday, Sunday
or a legal holiday, then such action may be taken or such
right may be exercised on the next succeeding day not a
Saturday, Sunday or legal holiday.
e) Authorized Shares. The Company covenants that during the
period the Warrant is outstanding, it will
reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the
Warrant Shares upon the exercise of any purchase rights under
this Warrant. The Company further covenants that its issuance
of this Warrant shall constitute full authority to its
officers who are charged with the duty of executing stock
certificates to execute and issue the necessary certificates
for the Warrant Shares upon the exercise of the purchase
rights under this Warrant. The Company will take all such
reasonable action as may be necessary to assure that such
Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any
requirements of the Trading Market upon which the Common Stock
may be listed.
10 of 15
Except and to the extent as waived or consented to by the
Holder, the Company shall not by any action, including,
without limitation, amending its certificate of incorporation
or through any reorganization, transfer of assets,
consolidation, merger, dissolution, issue or sale of
securities or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms of
this Warrant, but will at all times in good faith assist in
the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the
rights of Holder as set forth in this Warrant against
impairment. Without limiting the generality of the foregoing,
the Company will (a) not increase the par value of any Warrant
Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (b) take all
such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and
nonassessable Warrant Shares upon the exercise of this
Warrant, and (c) use commercially reasonable efforts to obtain
all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be
necessary to enable the Company to perform its obligations
under this Warrant.
Before taking any action which would result in an adjustment
in the number of Warrant Shares for which this Warrant is
exercisable or in the Exercise Price, the Company shall obtain
all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body
or bodies having jurisdiction thereof.
f) Jurisdiction. All questions concerning the construction,
validity, enforcement and interpretation of this Warrant shall
be determined in accordance with the provisions of the
Purchase Agreement.
g) Restrictions. The Holder acknowledges that the Warrant Shares
acquired upon the exercise of this Warrant, if not registered,
will have restrictions upon resale imposed by state and
federal securities laws.
h) Nonwaiver and Expenses. No course of dealing or any delay or
failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice
▇▇▇▇▇▇'s rights, powers or remedies, notwithstanding the fact
that all rights hereunder terminate on the Termination Date.
If the Company willfully and knowingly fails to comply with
any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to Holder such
amounts as shall be sufficient to cover any costs and expenses
including, but not limited to, reasonable attorneys' fees,
including those of appellate proceedings, incurred by Holder
in collecting any amounts due pursuant hereto or in otherwise
enforcing any of its rights, powers or remedies hereunder.
i) Notices. Any notice, request or other document required or
permitted to be given or delivered to the Holder by the
Company shall be delivered in accordance with the notice
provisions of the Purchase Agreement.
11 of 15
j) Limitation of Liability. No provision hereof, in the absence
of any affirmative action by Holder to exercise this Warrant
or purchase Warrant Shares, and no enumeration herein of the
rights or privileges of Holder, shall give rise to any
liability of Holder for the purchase price of any Common Stock
or as a stockholder of the Company, whether such liability is
asserted by the Company or by creditors of the Company.
k) Remedies. Holder, in addition to being entitled to exercise
all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this
Warrant. The Company agrees that monetary damages would not be
adequate compensation for any loss incurred by reason of a
breach by it of the provisions of this Warrant and hereby
agrees to waive the defense in any action for specific
performance that a remedy at law would be adequate.
l) Successors and Assigns. Subject to applicable securities laws,
this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the
successors of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended
to be for the benefit of all Holders from time to time of this
Warrant and shall be enforceable by any such Holder or holder
of Warrant Shares.
m) Amendment. This Warrant may be modified or amended or the
provisions hereof waived with the written consent of the
Company and the Holder.
n) Severability. Wherever possible, each provision of this
Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable
law, such provision shall be ineffective to the extent of such
prohibition or invalidity, without invalidating the remainder
of such provisions or the remaining provisions of this
Warrant.
o) Headings. The headings used in this Warrant are for the
convenience of reference only and shall not, for any purpose,
be deemed a part of this Warrant.
********************
12 of 15
IN WITNESS WHEREOF, the Company has caused this Warrant to be executed
by its officer thereunto duly authorized.
Dated: February 28, 2006
NEW CENTURY COMPANIES, INC.
---------------------------------------
Name:
Title:
13 of 15
NOTICE OF EXERCISE
TO: NEW CENTURY COMPANIES, INC.
(1) The undersigned hereby elects to purchase ________ Warrant Shares
of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together
with all applicable transfer taxes, if any.
(2)Payment shall take the form of (check applicable box):
[ ] in lawful money of the United States; or
[ ] the cancellation of such number of Warrant Shares as is
necessary, in accordance with the formula set forth in
subsection 2(c), to exercise this Warrant with respect to the
maximum number of Warrant Shares purchasable pursuant to the
cashless exercise procedure set forth in subsection 2(c).
(3)Please issue a certificate or certificates representing said
Warrant Shares in the name of the undersigned or in such other name as is
specified below:
-------------------------------
The Warrant Shares shall be delivered to the following:
-------------------------------
-------------------------------
-------------------------------
(4) Accredited Investor. The undersigned is an "accredited investor" as
defined in Regulation D promulgated under the Securities Act of 1933, as
amended.
[SIGNATURE OF HOLDER]
Name of Investing Entity:
-------------------------------------------------------
Signature of Authorized Signatory of Investing Entity:
--------------------------
Name of Authorized Signatory:
---------------------------------------------------
Title of Authorized Signatory:
--------------------------------------------------
Date:
---------------------------------------------------------------------------
ASSIGNMENT FORM
(To assign the foregoing warrant, execute
this form and supply required information.
Do not use this form to exercise the warrant.)
FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to
whose address is
--------------------------------
------------------------------------------------.
-----------------------------------------------------------------
Dated:
-----------,--------------
Holder's Signature:
------------------------------
Holder's Address:
------------------------------
------------------------------
Signature Guaranteed:
-----------------------------
NOTE: The signature to this Assignment Form must correspond with the name as it
appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers
of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.